

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil mediated immunity (GO:0002446) | 6.36247966 |
| 2 | negative regulation of phagocytosis (GO:0050765) | 6.34380851 |
| 3 | respiratory burst (GO:0045730) | 6.18147066 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.10628587 |
| 5 | cellular extravasation (GO:0045123) | 5.34372444 |
| 6 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.30608419 |
| 7 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.23503765 |
| 8 | regulation of growth of symbiont in host (GO:0044126) | 5.23503765 |
| 9 | negative regulation of growth of symbiont in host (GO:0044130) | 5.23503765 |
| 10 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.23503765 |
| 11 | adenosine receptor signaling pathway (GO:0001973) | 5.20974215 |
| 12 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.19886204 |
| 13 | pinocytosis (GO:0006907) | 4.95482031 |
| 14 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.94428217 |
| 15 | positive regulation of mast cell degranulation (GO:0043306) | 4.94428217 |
| 16 | angiogenesis involved in wound healing (GO:0060055) | 4.86046916 |
| 17 | mast cell activation (GO:0045576) | 4.79951486 |
| 18 | myeloid leukocyte mediated immunity (GO:0002444) | 4.77432004 |
| 19 | mast cell activation involved in immune response (GO:0002279) | 4.71867684 |
| 20 | mast cell degranulation (GO:0043303) | 4.71867684 |
| 21 | negative regulation of granulocyte differentiation (GO:0030853) | 4.63504114 |
| 22 | lipoxygenase pathway (GO:0019372) | 4.53394727 |
| 23 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.38776113 |
| 24 | reactive oxygen species biosynthetic process (GO:1903409) | 4.36117832 |
| 25 | response to peptidoglycan (GO:0032494) | 4.34174252 |
| 26 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.33212756 |
| 27 | T cell migration (GO:0072678) | 4.31414268 |
| 28 | regulation of platelet activation (GO:0010543) | 4.31309708 |
| 29 | response to fungus (GO:0009620) | 4.30687737 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 4.29818881 |
| 31 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.26782519 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 4.24774650 |
| 33 | thrombin receptor signaling pathway (GO:0070493) | 4.23350977 |
| 34 | positive regulation of receptor recycling (GO:0001921) | 4.21265203 |
| 35 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.20618517 |
| 36 | low-density lipoprotein particle remodeling (GO:0034374) | 4.20617616 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16790640 |
| 38 | regulation of platelet aggregation (GO:0090330) | 4.15607686 |
| 39 | virion attachment to host cell (GO:0019062) | 4.14477777 |
| 40 | adhesion of symbiont to host cell (GO:0044650) | 4.14477777 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.11610558 |
| 42 | leukocyte degranulation (GO:0043299) | 4.09752026 |
| 43 | neutrophil activation (GO:0042119) | 4.07881600 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.99392064 |
| 45 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.98345246 |
| 46 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.98345246 |
| 47 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.97807561 |
| 48 | positive regulation of T cell chemotaxis (GO:0010820) | 3.92798845 |
| 49 | regulation of T cell chemotaxis (GO:0010819) | 3.92798845 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.91417450 |
| 51 | adhesion of symbiont to host (GO:0044406) | 3.90212684 |
| 52 | regulation of mast cell activation (GO:0033003) | 3.85524723 |
| 53 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.84971365 |
| 54 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.83918065 |
| 55 | lymphocyte chemotaxis (GO:0048247) | 3.78375369 |
| 56 | positive regulation of leukocyte degranulation (GO:0043302) | 3.78136512 |
| 57 | dendritic cell chemotaxis (GO:0002407) | 3.75933593 |
| 58 | granulocyte activation (GO:0036230) | 3.74658958 |
| 59 | defense response to fungus (GO:0050832) | 3.68257568 |
| 60 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.66082404 |
| 61 | negative regulation of mast cell activation (GO:0033004) | 3.65525168 |
| 62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.65064699 |
| 63 | leukocyte mediated cytotoxicity (GO:0001909) | 3.64988772 |
| 64 | microglial cell activation (GO:0001774) | 3.63693559 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62457650 |
| 66 | eosinophil chemotaxis (GO:0048245) | 3.62087572 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 3.59490483 |
| 68 | leukotriene biosynthetic process (GO:0019370) | 3.59226273 |
| 69 | phagocytosis, engulfment (GO:0006911) | 3.57360691 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.56207532 |
| 71 | regulation of leukocyte degranulation (GO:0043300) | 3.54125751 |
| 72 | dendritic cell migration (GO:0036336) | 3.50815556 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49784020 |
| 74 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.49784020 |
| 75 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49082482 |
| 76 | negative regulation of B cell proliferation (GO:0030889) | 3.48245669 |
| 77 | regulation of monocyte chemotaxis (GO:0090025) | 3.47437059 |
| 78 | leukotriene metabolic process (GO:0006691) | 3.47153696 |
| 79 | cellular response to zinc ion (GO:0071294) | 3.46308971 |
| 80 | eosinophil migration (GO:0072677) | 3.45227375 |
| 81 | negative regulation of interleukin-17 production (GO:0032700) | 3.42662579 |
| 82 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.42128532 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.36616908 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 3.36125262 |
| 85 | regulation of macrophage chemotaxis (GO:0010758) | 3.35711749 |
| 86 | platelet aggregation (GO:0070527) | 3.35500955 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.35210215 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35001709 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 3.35001709 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35001709 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35001709 |
| 92 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35001709 |
| 93 | modulation by symbiont of host immune response (GO:0052553) | 3.35001709 |
| 94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.32960816 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 3.23677212 |
| 96 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.23450494 |
| 97 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.22950861 |
| 98 | regulation of lymphocyte migration (GO:2000401) | 3.22390058 |
| 99 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.21092542 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.19409596 |
| 101 | megakaryocyte development (GO:0035855) | 3.18821354 |
| 102 | regulation of B cell differentiation (GO:0045577) | 3.18645502 |
| 103 | heart contraction (GO:0060047) | 3.15941405 |
| 104 | heart process (GO:0003015) | 3.15941405 |
| 105 | mannose metabolic process (GO:0006013) | 3.14233126 |
| 106 | histamine secretion (GO:0001821) | 3.13533625 |
| 107 | macrophage activation (GO:0042116) | 3.09843726 |
| 108 | N-acetylneuraminate metabolic process (GO:0006054) | 3.09241104 |
| 109 | protein neddylation (GO:0045116) | 3.08605335 |
| 110 | positive regulation of lymphocyte migration (GO:2000403) | 3.08332351 |
| 111 | positive regulation of macrophage differentiation (GO:0045651) | 3.08263596 |
| 112 | negative regulation of platelet activation (GO:0010544) | 3.04168364 |
| 113 | regulation of phagocytosis (GO:0050764) | 3.02929806 |
| 114 | myeloid leukocyte activation (GO:0002274) | 3.01342777 |
| 115 | detection of other organism (GO:0098543) | 3.00407367 |
| 116 | regulation of early endosome to late endosome transport (GO:2000641) | 3.00178649 |
| 117 | regulation of regulated secretory pathway (GO:1903305) | 2.99913954 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 2.99606498 |
| 119 | purinergic receptor signaling pathway (GO:0035587) | 2.99229641 |
| 120 | regulation of apoptotic cell clearance (GO:2000425) | 2.98731285 |
| 121 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.98478777 |
| 122 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91377699 |
| 123 | positive regulation of T cell migration (GO:2000406) | 2.91013787 |
| 124 | B cell mediated immunity (GO:0019724) | 2.90371700 |
| 125 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.90313934 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.89924524 |
| 127 | regulation of mononuclear cell migration (GO:0071675) | 2.89524518 |
| 128 | negative regulation of cell killing (GO:0031342) | 2.87921094 |
| 129 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87921094 |
| 130 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.87295063 |
| 131 | hepatocyte apoptotic process (GO:0097284) | 2.86050728 |
| 132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85680291 |
| 133 | detection of external biotic stimulus (GO:0098581) | 2.85447121 |
| 134 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.84733200 |
| 135 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.84487601 |
| 136 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.84346340 |
| 137 | killing of cells of other organism (GO:0031640) | 2.84320791 |
| 138 | disruption of cells of other organism (GO:0044364) | 2.84320791 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.83063689 |
| 140 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82578335 |
| 141 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82578335 |
| 142 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.82552117 |
| 143 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.77982132 |
| 144 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77674387 |
| 145 | response to host immune response (GO:0052572) | 2.77674387 |
| 146 | negative regulation of type 2 immune response (GO:0002829) | 2.76988793 |
| 147 | positive regulation of type 2 immune response (GO:0002830) | 2.74761596 |
| 148 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74760295 |
| 149 | positive regulation of regulated secretory pathway (GO:1903307) | 2.74650670 |
| 150 | positive regulation of chemokine secretion (GO:0090197) | 2.69315622 |
| 151 | actin filament polymerization (GO:0030041) | 2.68723923 |
| 152 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.67798913 |
| 153 | positive regulation of B cell mediated immunity (GO:0002714) | 2.66750149 |
| 154 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.66750149 |
| 155 | regulation of receptor recycling (GO:0001919) | 2.65133683 |
| 156 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.64072452 |
| 157 | positive regulation of blood coagulation (GO:0030194) | 2.63845275 |
| 158 | positive regulation of hemostasis (GO:1900048) | 2.63845275 |
| 159 | peptide catabolic process (GO:0043171) | 2.63746319 |
| 160 | membrane invagination (GO:0010324) | 2.61278322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.66741045 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.57184277 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.21121976 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.95222020 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.92579274 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.91307491 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.76029714 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.61213590 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.41154246 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34171192 |
| 11 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.18744484 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89079706 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.81450631 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77992825 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75375135 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.72673400 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.70498805 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63514626 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.62281167 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.61440711 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.53177885 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.49502227 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.37599368 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.29741177 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22420069 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.13708513 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11946706 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06354583 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03384122 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00698356 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00570419 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95119794 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90812931 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85679538 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83673129 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.80142699 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79082518 |
| 38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.70380917 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67745079 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.66727927 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65221609 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63621889 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58920496 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56929166 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55584414 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53667514 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53446136 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.52043206 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.51823420 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51132234 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.47990903 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47793612 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40353546 |
| 54 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40049477 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38627078 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35659889 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34962221 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32778223 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32082352 |
| 60 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.30709175 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28918518 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27303852 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25455522 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24454489 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24017061 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23370829 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20302421 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18816662 |
| 69 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18303536 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17956657 |
| 71 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.17510816 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16733872 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14593259 |
| 74 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.14221264 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10847453 |
| 76 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.10771683 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10706997 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10614710 |
| 79 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08415241 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07917949 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05178284 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04579915 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04301620 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03935532 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03814453 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03075330 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03075330 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01647536 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01400561 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99658815 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99469923 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98690801 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96784042 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96149493 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93485660 |
| 96 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.92011087 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91020056 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90117141 |
| 99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87983690 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87208178 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85448192 |
| 102 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.85403253 |
| 103 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.84948185 |
| 104 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81728536 |
| 105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81214049 |
| 106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79947741 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79709747 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77661221 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77140472 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76629046 |
| 111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.76140087 |
| 112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76031318 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75062305 |
| 114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72969130 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71922618 |
| 116 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71818556 |
| 117 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.71750274 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71676055 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71123685 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70301795 |
| 121 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.69963122 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69871284 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69785584 |
| 124 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.69698663 |
| 125 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68325368 |
| 126 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68283720 |
| 127 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.68007043 |
| 128 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.67551738 |
| 129 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66875157 |
| 130 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.66766592 |
| 131 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.63645599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 4.29902301 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.95180103 |
| 3 | MP0003436_decreased_susceptibility_to | 3.79556300 |
| 4 | MP0002419_abnormal_innate_immunity | 3.29964177 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.27259360 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.26283637 |
| 7 | MP0002396_abnormal_hematopoietic_system | 3.12326260 |
| 8 | MP0003724_increased_susceptibility_to | 3.06743609 |
| 9 | MP0009785_altered_susceptibility_to | 2.74558458 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.68637131 |
| 11 | MP0005025_abnormal_response_to | 2.61134939 |
| 12 | MP0004510_myositis | 2.52639814 |
| 13 | MP0006054_spinal_hemorrhage | 2.52618460 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.51526642 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.32589997 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.31467199 |
| 17 | MP0009840_abnormal_foam_cell | 2.25035805 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.24280599 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.24193486 |
| 20 | * MP0000343_altered_response_to | 2.22010997 |
| 21 | MP0001800_abnormal_humoral_immune | 2.19798782 |
| 22 | MP0003690_abnormal_glial_cell | 2.15529535 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.15075362 |
| 24 | MP0005671_abnormal_response_to | 2.07672021 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.07244030 |
| 26 | MP0000604_amyloidosis | 2.06717992 |
| 27 | MP0003075_altered_response_to | 2.04336906 |
| 28 | MP0001819_abnormal_immune_cell | 2.03376429 |
| 29 | MP0002723_abnormal_immune_serum | 1.98237043 |
| 30 | MP0002006_tumorigenesis | 1.90123840 |
| 31 | MP0001790_abnormal_immune_system | 1.81766609 |
| 32 | MP0005387_immune_system_phenotype | 1.81766609 |
| 33 | MP0002405_respiratory_system_inflammati | 1.80284179 |
| 34 | MP0008057_abnormal_DNA_replication | 1.78859913 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.77526914 |
| 36 | MP0003303_peritoneal_inflammation | 1.77267017 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.75692828 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.68605615 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.65231426 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.64809979 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.64364292 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.58580036 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.54850493 |
| 44 | MP0005164_abnormal_response_to | 1.54458288 |
| 45 | MP0000858_altered_metastatic_potential | 1.53408760 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.53206327 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.53206327 |
| 48 | MP0000716_abnormal_immune_system | 1.51650654 |
| 49 | MP0010307_abnormal_tumor_latency | 1.51134130 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.50367890 |
| 51 | MP0002398_abnormal_bone_marrow | 1.49134888 |
| 52 | MP0001853_heart_inflammation | 1.47791494 |
| 53 | MP0003448_altered_tumor_morphology | 1.47160676 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.45535959 |
| 55 | MP0000685_abnormal_immune_system | 1.41915416 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.40957219 |
| 57 | MP0008469_abnormal_protein_level | 1.35858080 |
| 58 | MP0002429_abnormal_blood_cell | 1.33763762 |
| 59 | MP0004130_abnormal_muscle_cell | 1.31474120 |
| 60 | MP0009764_decreased_sensitivity_to | 1.31094434 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.30273089 |
| 62 | MP0002722_abnormal_immune_system | 1.28828638 |
| 63 | MP0008260_abnormal_autophagy | 1.25445516 |
| 64 | MP0002009_preneoplasia | 1.21685521 |
| 65 | MP0004883_abnormal_blood_vessel | 1.21594107 |
| 66 | MP0005083_abnormal_biliary_tract | 1.20818910 |
| 67 | MP0000490_abnormal_crypts_of | 1.15325001 |
| 68 | MP0003638_abnormal_response/metabolism_ | 1.14972450 |
| 69 | MP0003828_pulmonary_edema | 1.13369051 |
| 70 | MP0005166_decreased_susceptibility_to | 1.12965345 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.12930515 |
| 72 | MP0003866_abnormal_defecation | 1.12793569 |
| 73 | MP0001915_intracranial_hemorrhage | 1.09240867 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.08457468 |
| 75 | MP0010094_abnormal_chromosome_stability | 1.07664890 |
| 76 | MP0000249_abnormal_blood_vessel | 1.07265053 |
| 77 | MP0004147_increased_porphyrin_level | 1.05454157 |
| 78 | MP0003329_amyloid_beta_deposits | 1.04765433 |
| 79 | MP0002132_abnormal_respiratory_system | 1.03508754 |
| 80 | MP0003091_abnormal_cell_migration | 1.03221831 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.99087766 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.98560038 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.97971777 |
| 84 | MP0005409_darkened_coat_color | 0.97565024 |
| 85 | MP0008873_increased_physiological_sensi | 0.96238416 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.95394998 |
| 87 | MP0005390_skeleton_phenotype | 0.94455689 |
| 88 | * MP0009763_increased_sensitivity_to | 0.94249497 |
| 89 | MP0005310_abnormal_salivary_gland | 0.92302083 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.91540951 |
| 91 | MP0003279_aneurysm | 0.91227450 |
| 92 | MP0006082_CNS_inflammation | 0.86781383 |
| 93 | MP0001663_abnormal_digestive_system | 0.86368401 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.85824839 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.85257270 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.84211220 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.83467751 |
| 98 | MP0003111_abnormal_nucleus_morphology | 0.83146757 |
| 99 | MP0001851_eye_inflammation | 0.82296175 |
| 100 | MP0001958_emphysema | 0.82173877 |
| 101 | MP0003186_abnormal_redox_activity | 0.82020266 |
| 102 | MP0002933_joint_inflammation | 0.79746563 |
| 103 | MP0001542_abnormal_bone_strength | 0.78180663 |
| 104 | MP0003693_abnormal_embryo_hatching | 0.78092278 |
| 105 | MP0010352_gastrointestinal_tract_polyps | 0.78080325 |
| 106 | MP0005647_abnormal_sex_gland | 0.77387097 |
| 107 | MP0008874_decreased_physiological_sensi | 0.76511180 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.76008576 |
| 109 | MP0005165_increased_susceptibility_to | 0.75576977 |
| 110 | MP0005023_abnormal_wound_healing | 0.74676849 |
| 111 | MP0009278_abnormal_bone_marrow | 0.73982195 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.73344840 |
| 113 | MP0003879_abnormal_hair_cell | 0.73304582 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.72452772 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.71640794 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.70845071 |
| 117 | MP0003795_abnormal_bone_structure | 0.70712671 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.70272211 |
| 119 | MP0003077_abnormal_cell_cycle | 0.69850880 |
| 120 | MP0004947_skin_inflammation | 0.69801931 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.69611690 |
| 122 | MP0000920_abnormal_myelination | 0.69100273 |
| 123 | MP0002254_reproductive_system_inflammat | 0.68786646 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.68547297 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68346684 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.67159831 |
| 127 | MP0002971_abnormal_brown_adipose | 0.67133118 |
| 128 | MP0005365_abnormal_bile_salt | 0.66844800 |
| 129 | MP0010368_abnormal_lymphatic_system | 0.63645548 |
| 130 | MP0004484_altered_response_of | 0.62870943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Purpura (HP:0000979) | 6.56979437 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.51720135 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.24826558 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 6.22125620 |
| 5 | Increased mean platelet volume (HP:0011877) | 6.19463243 |
| 6 | Menorrhagia (HP:0000132) | 5.73788181 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.29974999 |
| 8 | * Epistaxis (HP:0000421) | 5.23621743 |
| 9 | Gingival bleeding (HP:0000225) | 5.22907334 |
| 10 | Glomerulonephritis (HP:0000099) | 4.63511346 |
| 11 | Myositis (HP:0100614) | 4.56814683 |
| 12 | Thrombocytosis (HP:0001894) | 4.38796517 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30759744 |
| 14 | Papilledema (HP:0001085) | 4.24309701 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.11389087 |
| 16 | Abnormality of complement system (HP:0005339) | 4.01871510 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.97651743 |
| 18 | Orchitis (HP:0100796) | 3.92636194 |
| 19 | Impaired platelet aggregation (HP:0003540) | 3.91490235 |
| 20 | Abnormal platelet function (HP:0011869) | 3.91490235 |
| 21 | Complement deficiency (HP:0004431) | 3.77381861 |
| 22 | * Spontaneous hematomas (HP:0007420) | 3.62510324 |
| 23 | Abnormality of the prostate (HP:0008775) | 3.58776736 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.52855560 |
| 25 | Obstructive lung disease (HP:0006536) | 3.52704753 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.52704753 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.49123264 |
| 28 | Agnosia (HP:0010524) | 3.45854275 |
| 29 | Recurrent skin infections (HP:0001581) | 3.40960254 |
| 30 | Periodontitis (HP:0000704) | 3.38001037 |
| 31 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.36137547 |
| 32 | Mutism (HP:0002300) | 3.32667421 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.30978783 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.29909837 |
| 35 | Optic neuritis (HP:0100653) | 3.29909837 |
| 36 | IgM deficiency (HP:0002850) | 3.17884606 |
| 37 | Abnormality of macrophages (HP:0004311) | 3.17276992 |
| 38 | Cellulitis (HP:0100658) | 3.16082891 |
| 39 | Gingivitis (HP:0000230) | 3.14261994 |
| 40 | Meningitis (HP:0001287) | 3.14109235 |
| 41 | Conjunctival telangiectasia (HP:0000524) | 3.03113032 |
| 42 | Recurrent viral infections (HP:0004429) | 3.02815253 |
| 43 | Stomatitis (HP:0010280) | 3.00188217 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.96714642 |
| 45 | Petechiae (HP:0000967) | 2.96129965 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.92980547 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.92054550 |
| 48 | Eosinophilia (HP:0001880) | 2.91103607 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.88018200 |
| 50 | Hyperlipoproteinemia (HP:0010980) | 2.86303980 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.81604503 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.76979098 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.75487660 |
| 54 | Nephritis (HP:0000123) | 2.67847677 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.67468575 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.66965570 |
| 57 | Disinhibition (HP:0000734) | 2.64903740 |
| 58 | Granulocytopenia (HP:0001913) | 2.62050613 |
| 59 | Chronic otitis media (HP:0000389) | 2.60297362 |
| 60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.58712707 |
| 61 | Osteomyelitis (HP:0002754) | 2.58249422 |
| 62 | Chest pain (HP:0100749) | 2.50322524 |
| 63 | Thick nail (HP:0001805) | 2.47035198 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46407476 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.46407476 |
| 66 | Cutaneous melanoma (HP:0012056) | 2.44795096 |
| 67 | Axonal loss (HP:0003447) | 2.44643509 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.43719943 |
| 69 | * Bruising susceptibility (HP:0000978) | 2.43136180 |
| 70 | Leukocytosis (HP:0001974) | 2.42895773 |
| 71 | Peritonitis (HP:0002586) | 2.38432309 |
| 72 | Amyloidosis (HP:0011034) | 2.35919038 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.34259278 |
| 74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30342096 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30342096 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30342096 |
| 77 | Loss of speech (HP:0002371) | 2.25904316 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 2.24775160 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24775160 |
| 80 | Pustule (HP:0200039) | 2.21462615 |
| 81 | Vertigo (HP:0002321) | 2.19096539 |
| 82 | Vasculitis (HP:0002633) | 2.17441429 |
| 83 | Arterial thrombosis (HP:0004420) | 2.17301812 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.17156604 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14093499 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14093499 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14093499 |
| 88 | Thoracic kyphosis (HP:0002942) | 2.13639573 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.12101496 |
| 90 | Spinal muscular atrophy (HP:0007269) | 2.11821143 |
| 91 | Dyschromatopsia (HP:0007641) | 2.09668089 |
| 92 | Hematochezia (HP:0002573) | 2.08861685 |
| 93 | B lymphocytopenia (HP:0010976) | 2.08624075 |
| 94 | Abnormality of B cell number (HP:0010975) | 2.08624075 |
| 95 | Poikilocytosis (HP:0004447) | 2.08348575 |
| 96 | Premature loss of primary teeth (HP:0006323) | 2.06564199 |
| 97 | Encephalitis (HP:0002383) | 2.06502757 |
| 98 | Keratitis (HP:0000491) | 2.06255274 |
| 99 | Urticaria (HP:0001025) | 2.06073622 |
| 100 | Nuclear cataract (HP:0100018) | 2.05442732 |
| 101 | Hemoptysis (HP:0002105) | 2.04962413 |
| 102 | Myocardial infarction (HP:0001658) | 2.04774235 |
| 103 | Increased serum ferritin (HP:0003281) | 2.03886928 |
| 104 | Abnormality of eosinophils (HP:0001879) | 2.03406715 |
| 105 | Panhypogammaglobulinemia (HP:0003139) | 2.02808224 |
| 106 | Increased density of long bones (HP:0006392) | 2.02623199 |
| 107 | Sepsis (HP:0100806) | 2.00441455 |
| 108 | Basal ganglia calcification (HP:0002135) | 1.99839201 |
| 109 | Mucosal telangiectasiae (HP:0100579) | 1.99145116 |
| 110 | Gangrene (HP:0100758) | 1.98376212 |
| 111 | Skin ulcer (HP:0200042) | 1.97884082 |
| 112 | Nonimmune hydrops fetalis (HP:0001790) | 1.97404258 |
| 113 | Joint swelling (HP:0001386) | 1.96692698 |
| 114 | Ventricular fibrillation (HP:0001663) | 1.96495495 |
| 115 | Abnormality of the lumbar spine (HP:0100712) | 1.95906292 |
| 116 | Chromsome breakage (HP:0040012) | 1.95897600 |
| 117 | Abnormal pupillary function (HP:0007686) | 1.93811393 |
| 118 | Gastrointestinal inflammation (HP:0004386) | 1.92531714 |
| 119 | Abnormality of T cells (HP:0002843) | 1.92384788 |
| 120 | Recurrent lower respiratory tract infections (HP:0002783) | 1.91666144 |
| 121 | Acanthocytosis (HP:0001927) | 1.91240789 |
| 122 | Prolonged bleeding time (HP:0003010) | 1.89451952 |
| 123 | Prostate neoplasm (HP:0100787) | 1.89232101 |
| 124 | Deformed sella turcica (HP:0002681) | 1.88820888 |
| 125 | Asymmetric septal hypertrophy (HP:0001670) | 1.88699154 |
| 126 | Abnormality of the thoracic spine (HP:0100711) | 1.88265949 |
| 127 | Recurrent bronchitis (HP:0002837) | 1.88214431 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.85505418 |
| 129 | Paralysis (HP:0003470) | 1.85468202 |
| 130 | Episodic fever (HP:0001954) | 1.84952997 |
| 131 | Upper motor neuron abnormality (HP:0002127) | 1.83722099 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.82086031 |
| 133 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.81118290 |
| 134 | Gastrointestinal infarctions (HP:0005244) | 1.79733050 |
| 135 | Pulmonary embolism (HP:0002204) | 1.79707898 |
| 136 | Abnormal platelet volume (HP:0011876) | 1.79463828 |
| 137 | Tetraparesis (HP:0002273) | 1.78676679 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77280140 |
| 139 | Amaurosis fugax (HP:0100576) | 1.75573406 |
| 140 | Abnormality of lateral ventricle (HP:0030047) | 1.74519220 |
| 141 | Polycythemia (HP:0001901) | 1.74189756 |
| 142 | Neuronal loss in central nervous system (HP:0002529) | 1.70703590 |
| 143 | T lymphocytopenia (HP:0005403) | 1.68219435 |
| 144 | Thrombophlebitis (HP:0004418) | 1.67258093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.37641275 |
| 2 | IRAK4 | 3.83245866 |
| 3 | TEC | 3.74979761 |
| 4 | TYK2 | 3.10281128 |
| 5 | MAP3K14 | 3.07011630 |
| 6 | BTK | 2.81953969 |
| 7 | KIT | 2.76068531 |
| 8 | TAOK3 | 2.51337567 |
| 9 | CLK1 | 2.41346251 |
| 10 | ERN1 | 2.25731371 |
| 11 | BMX | 2.13104227 |
| 12 | EIF2AK1 | 2.11543815 |
| 13 | ITK | 2.08087225 |
| 14 | TGFBR2 | 2.01760399 |
| 15 | EPHB1 | 2.00349836 |
| 16 | STK10 | 1.93236155 |
| 17 | EEF2K | 1.88933797 |
| 18 | MAP2K3 | 1.85034734 |
| 19 | RIPK4 | 1.76814025 |
| 20 | CSF1R | 1.73934154 |
| 21 | FGR | 1.70722749 |
| 22 | IRAK3 | 1.67828277 |
| 23 | SCYL2 | 1.62831374 |
| 24 | MST4 | 1.61906433 |
| 25 | MAP4K1 | 1.60117857 |
| 26 | BMPR2 | 1.58637755 |
| 27 | PIK3CG | 1.58352897 |
| 28 | GRK7 | 1.52884801 |
| 29 | SYK | 1.52726798 |
| 30 | FES | 1.43760010 |
| 31 | TRPM7 | 1.39839700 |
| 32 | PTK2B | 1.36783789 |
| 33 | TNK2 | 1.35084182 |
| 34 | LYN | 1.34133963 |
| 35 | HCK | 1.32462355 |
| 36 | JAK1 | 1.30037554 |
| 37 | ZAP70 | 1.26960221 |
| 38 | MATK | 1.18335441 |
| 39 | NEK9 | 1.17432565 |
| 40 | JAK2 | 1.12733249 |
| 41 | IKBKE | 1.10185197 |
| 42 | CSK | 1.07896964 |
| 43 | TTN | 1.06916870 |
| 44 | PDK1 | 1.02215002 |
| 45 | PAK4 | 1.00497353 |
| 46 | IKBKB | 1.00167179 |
| 47 | MAP3K6 | 0.99925591 |
| 48 | CAMK1G | 0.98883111 |
| 49 | TSSK6 | 0.97237974 |
| 50 | PDPK1 | 0.96741926 |
| 51 | TESK2 | 0.96633240 |
| 52 | STK16 | 0.94849952 |
| 53 | PIM2 | 0.94559543 |
| 54 | TBK1 | 0.93835907 |
| 55 | RPS6KL1 | 0.92818795 |
| 56 | RPS6KC1 | 0.92818795 |
| 57 | LCK | 0.92732789 |
| 58 | FLT3 | 0.91581432 |
| 59 | LRRK2 | 0.88525282 |
| 60 | NEK1 | 0.88216843 |
| 61 | MAP3K5 | 0.88121371 |
| 62 | GRK5 | 0.87530201 |
| 63 | MAP3K1 | 0.87071165 |
| 64 | RPS6KA6 | 0.85997210 |
| 65 | CDK6 | 0.85825999 |
| 66 | EIF2AK2 | 0.85386453 |
| 67 | RPS6KA2 | 0.85331008 |
| 68 | MAPKAPK3 | 0.84756086 |
| 69 | ZAK | 0.83071413 |
| 70 | ABL2 | 0.82529853 |
| 71 | IRAK1 | 0.82227111 |
| 72 | TXK | 0.80818322 |
| 73 | STK4 | 0.80376405 |
| 74 | MAPK12 | 0.80168171 |
| 75 | STK3 | 0.80085474 |
| 76 | EPHA3 | 0.78528772 |
| 77 | ARAF | 0.77698830 |
| 78 | TGFBR1 | 0.77248488 |
| 79 | MAP3K13 | 0.76436235 |
| 80 | ADRBK2 | 0.74652670 |
| 81 | PIM1 | 0.73122791 |
| 82 | TAOK2 | 0.72773230 |
| 83 | ATR | 0.72421389 |
| 84 | MARK3 | 0.72046789 |
| 85 | SIK3 | 0.70999777 |
| 86 | DAPK1 | 0.70626362 |
| 87 | STK24 | 0.67957835 |
| 88 | PRKD1 | 0.66711786 |
| 89 | PRKCD | 0.65545227 |
| 90 | MAP3K11 | 0.65317063 |
| 91 | PASK | 0.64542248 |
| 92 | ADRBK1 | 0.64343543 |
| 93 | RET | 0.63905178 |
| 94 | JAK3 | 0.63430527 |
| 95 | TAOK1 | 0.62738039 |
| 96 | CAMK1D | 0.61770592 |
| 97 | ILK | 0.60108559 |
| 98 | VRK1 | 0.59974297 |
| 99 | PDGFRB | 0.59954850 |
| 100 | YES1 | 0.59452624 |
| 101 | SGK3 | 0.58930562 |
| 102 | BUB1 | 0.58658947 |
| 103 | FER | 0.58648585 |
| 104 | CDC42BPA | 0.58203332 |
| 105 | PAK1 | 0.57269156 |
| 106 | ACVR1B | 0.54983741 |
| 107 | MAP3K3 | 0.52317253 |
| 108 | GRK6 | 0.52304721 |
| 109 | EIF2AK3 | 0.52055925 |
| 110 | DAPK2 | 0.51103245 |
| 111 | MAPK4 | 0.50971510 |
| 112 | MAP3K8 | 0.50567414 |
| 113 | ABL1 | 0.50131890 |
| 114 | SGK2 | 0.50004878 |
| 115 | TESK1 | 0.48511403 |
| 116 | IRAK2 | 0.48035386 |
| 117 | CAMKK2 | 0.47801029 |
| 118 | TTK | 0.47712291 |
| 119 | CHUK | 0.47305854 |
| 120 | BRSK2 | 0.46322268 |
| 121 | MAPKAPK2 | 0.45966426 |
| 122 | NEK2 | 0.45820451 |
| 123 | MAPK7 | 0.45273012 |
| 124 | FGFR3 | 0.45003736 |
| 125 | KSR2 | 0.44901716 |
| 126 | PRKCQ | 0.44063497 |
| 127 | DDR2 | 0.43342920 |
| 128 | MAPKAPK5 | 0.43195348 |
| 129 | MARK2 | 0.42512540 |
| 130 | RPS6KB1 | 0.41965261 |
| 131 | MAP3K12 | 0.41853599 |
| 132 | TRIB3 | 0.38589125 |
| 133 | IGF1R | 0.38427361 |
| 134 | MYLK | 0.38360496 |
| 135 | PRPF4B | 0.38194584 |
| 136 | DAPK3 | 0.37980464 |
| 137 | PRKACG | 0.36787909 |
| 138 | FRK | 0.36447717 |
| 139 | PRKG1 | 0.35504765 |
| 140 | FYN | 0.34697069 |
| 141 | TLK1 | 0.33828347 |
| 142 | PLK3 | 0.32595957 |
| 143 | CDK4 | 0.27592649 |
| 144 | CDC7 | 0.26614111 |
| 145 | RPS6KA4 | 0.25748881 |
| 146 | HIPK2 | 0.24980234 |
| 147 | MOS | 0.24660854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.65801307 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22530761 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.18727632 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.16221104 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.06738858 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.68068238 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.58123259 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.47324122 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40782770 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.15263102 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.93555742 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.92466628 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.89291452 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85870948 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.81498500 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81231038 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81222293 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.74463705 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74382436 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.66904246 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66043448 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65545557 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61141487 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57308288 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55312708 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54480754 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.44599484 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42741402 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36413207 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35085677 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34962159 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32134164 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.29930499 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19996637 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19884763 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19220971 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.18934878 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.18643087 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17716329 |
| 40 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12179823 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10624749 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09898479 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.07345367 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07020036 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04401538 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04208614 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04073267 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99678734 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.97708465 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96981900 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96801594 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96499218 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95726147 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95335955 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.95119340 |
| 56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94962761 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94506041 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93485747 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92359973 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91574882 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90411264 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.89219447 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.88236874 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84884748 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84041342 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83893543 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.83485993 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81536416 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80009095 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78476196 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.78408998 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76631748 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76093796 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75718668 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73815401 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73159013 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72413466 |
| 78 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69894526 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68834444 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66745183 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65838352 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65507950 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64386158 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63763551 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63663032 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.62274682 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61658034 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60841219 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60186529 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59626877 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59390376 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59229204 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58722879 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.53705688 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53147307 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51791480 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51645406 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51636012 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.51344998 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.50470578 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49835525 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49755392 |
| 103 | Protein export_Homo sapiens_hsa03060 | 0.49578691 |
| 104 | Cell cycle_Homo sapiens_hsa04110 | 0.48751177 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48668407 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.47410604 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46304193 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45900706 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45888596 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45508909 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45376512 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44741398 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43805047 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42833475 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42163768 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39408299 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.36752353 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36388799 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35895962 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35815514 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35752757 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35072218 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34516192 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.34189894 |
| 125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33954692 |
| 126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33509114 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.32777051 |
| 128 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29432156 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29160667 |
| 130 | Allograft rejection_Homo sapiens_hsa05330 | 0.28294836 |
| 131 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.25488186 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24482669 |
| 133 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.22298405 |

